Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

ISLES 2016 and 2017-Benchmarking Ischemic Stroke Lesion Outcome Prediction Based on Multispectral MRI.

Winzeck S, Hakim A, McKinley R, Pinto JAADSR, Alves V, Silva C, Pisov M, Krivov E, Belyaev M, Monteiro M, Oliveira A, Choi Y, Paik MC, Kwon Y, Lee H, Kim BJ, Won JH, Islam M, Ren H, Robben D, Suetens P, Gong E, Niu Y, Xu J, Pauly JM, Lucas C, Heinrich MP, Rivera LC, Castillo LS, Daza LA, Beers AL, Arbelaezs P, Maier O, Chang K, Brown JM, Kalpathy-Cramer J, Zaharchuk G, Wiest R, Reyes M.

Front Neurol. 2018 Sep 13;9:679. doi: 10.3389/fneur.2018.00679. eCollection 2018.

2.

Cox model with interval-censored covariate in cohort studies.

Ahn S, Lim J, Paik MC, Sacco RL, Elkind MS.

Biom J. 2018 Jul;60(4):797-814. doi: 10.1002/bimj.201700090. Epub 2018 May 18.

3.

Erratum to: Evaluation of a technology-enhanced integrated care model for frail older persons: protocol of the SPEC study, a stepped-wedge cluster randomized trial in nursing homes.

Kim H, Park YH, Jung YI, Choi H, Lee S, Kim GS, Yang DW, Paik MC, Lee TJ.

BMC Geriatr. 2017 May 15;17(1):106. doi: 10.1186/s12877-017-0495-3. No abstract available.

4.

Evaluation of a technology-enhanced integrated care model for frail older persons: protocol of the SPEC study, a stepped-wedge cluster randomized trial in nursing homes.

Kim H, Park YH, Jung YI, Choi H, Lee S, Kim GS, Yang DW, Paik MC, Lee TJ.

BMC Geriatr. 2017 Apr 18;17(1):88. doi: 10.1186/s12877-017-0459-7. Erratum in: BMC Geriatr. 2017 May 15;17 (1):106.

5.

Cox proportional hazards models with left truncation and time-varying coefficient: Application of age at event as outcome in cohort studies.

Kim M, Paik MC, Jang J, Cheung YK, Willey J, Elkind MSV, Sacco RL.

Biom J. 2017 May;59(3):405-419. doi: 10.1002/bimj.201600003. Epub 2017 Feb 3.

PMID:
28160312
6.

Calibrated propensity score method for survey nonresponse in cluster sampling.

Kim JK, Kwon Y, Paik MC.

Biometrika. 2016 Jun;103(2):461-473. Epub 2016 Mar 17.

PMID:
27279670
7.

Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke: The Northern Manhattan Study.

Katan M, Moon YP, Paik MC, Mueller B, Huber A, Sacco RL, Elkind MS.

Stroke. 2016 Jul;47(7):1714-9. doi: 10.1161/STROKEAHA.115.011392. Epub 2016 May 19.

8.

Predictors and outcomes of unplanned readmission to a different hospital.

Kim H, Hung WW, Paik MC, Ross JS, Zhao Z, Kim GS, Boockvar K.

Int J Qual Health Care. 2015 Dec;27(6):513-9. doi: 10.1093/intqhc/mzv082. Epub 2015 Oct 15.

9.

Baseline Variation in Use of VA/DOD Clinical Practice Guideline Recommended Opioid Prescribing Practices Across VA Health Care Systems.

Buscaglia AC, Paik MC, Lewis E, Trafton JA; VA Opioid Metric Development Team.

Clin J Pain. 2015 Sep;31(9):803-812. doi: 10.1097/AJP.0000000000000160.

PMID:
29498628
10.

Association of Care Practices with Suicide Attempts in US Veterans Prescribed Opioid Medications for Chronic Pain Management.

Im JJ, Shachter RD, Oliva EM, Henderson PT, Paik MC, Trafton JA; PROGRES Team.

J Gen Intern Med. 2015 Jul;30(7):979-91. doi: 10.1007/s11606-015-3220-y. Epub 2015 Feb 19.

11.

Sex differences in chronic pain management practices for patients receiving opioids from the Veterans Health Administration.

Oliva EM, Midboe AM, Lewis ET, Henderson PT, Dalton AL, Im JJ, Seal K, Paik MC, Trafton JA.

Pain Med. 2015 Jan;16(1):112-8. doi: 10.1111/pme.12501. Epub 2014 Jul 13.

PMID:
25039721
12.

High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern Manhattan study.

Luna JM, Moon YP, Liu KM, Spitalnik S, Paik MC, Cheung K, Sacco RL, Elkind MS.

Stroke. 2014 Apr;45(4):979-87. doi: 10.1161/STROKEAHA.113.002289. Epub 2014 Mar 13.

13.

A marginal approach to reduced-rank penalized spline smoothing with application to multilevel functional data.

Chen H, Wang Y, Paik MC, Choi HA.

J Am Stat Assoc. 2013 Oct 1;108(504):1216-1229.

14.

Diabetes predicts long-term disability in an elderly urban cohort: the Northern Manhattan Study.

Dhamoon MS, Moon YP, Paik MC, Sacco RL, Elkind MS.

Ann Epidemiol. 2014 May;24(5):362-368.e1. doi: 10.1016/j.annepidem.2013.12.013. Epub 2014 Jan 3.

15.

Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: the Northern Manhattan Study.

Katan M, Moon YP, Paik MC, Wolfert RL, Sacco RL, Elkind MS.

PLoS One. 2014 Jan 9;9(1):e83393. doi: 10.1371/journal.pone.0083393. eCollection 2014.

16.

Infectious burden and cognitive function: the Northern Manhattan Study.

Katan M, Moon YP, Paik MC, Sacco RL, Wright CB, Elkind MS.

Neurology. 2013 Mar 26;80(13):1209-15. doi: 10.1212/WNL.0b013e3182896e79.

17.

Association between northern Manhattan study global vascular risk score and successful aging.

Warsch JR, Rundek T, Paik MC, Elkind MS, Sacco RL, Wright CB.

J Am Geriatr Soc. 2013 Apr;61(4):519-24. doi: 10.1111/jgs.12166. Epub 2013 Mar 25.

18.

Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study.

Economos A, Wright CB, Moon YP, Rundek T, Rabbani L, Paik MC, Sacco RL, Elkind MS.

Neuroepidemiology. 2013;40(4):253-9. doi: 10.1159/000343276. Epub 2013 Jan 24.

19.

Daytime sleepiness and risk of stroke and vascular disease: findings from the Northern Manhattan Study (NOMAS).

Boden-Albala B, Roberts ET, Bazil C, Moon Y, Elkind MS, Rundek T, Paik MC, Sacco RL.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):500-7. doi: 10.1161/CIRCOUTCOMES.111.963801. Epub 2012 Jul 10.

20.

Trajectory of functional decline before and after ischemic stroke: the Northern Manhattan Study.

Dhamoon MS, Moon YP, Paik MC, Sacco RL, Elkind MS.

Stroke. 2012 Aug;43(8):2180-4. doi: 10.1161/STROKEAHA.112.658922. Epub 2012 May 29.

21.

Heritability Estimation using Regression Models for Correlation.

Lee HS, Paik MC, Rundek T, Sacco RL, Dong C, Krischer JP.

J Biom Biostat. 2011 Nov 15;2(119). pii: 2666.

22.

Coronary death and myocardial infarction among Hispanics in the Northern Manhattan Study: exploring the Hispanic paradox.

Willey JZ, Rodriguez CJ, Moon YP, Paik MC, Di Tullio MR, Homma S, Sacco RL, Elkind MS.

Ann Epidemiol. 2012 May;22(5):303-9. doi: 10.1016/j.annepidem.2012.02.014. Epub 2012 Mar 15.

23.

Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study.

Banerjee C, Moon YP, Paik MC, Rundek T, Mora-McLaughlin C, Vieira JR, Sacco RL, Elkind MS.

Stroke. 2012 May;43(5):1212-7. doi: 10.1161/STROKEAHA.111.641381. Epub 2012 Mar 1.

24.

Measurement of adherence to clinical practice guidelines for opioid therapy for chronic pain.

Midboe AM, Lewis ET, Paik MC, Gallagher RM, Rosenberg JM, Goodman F, Kerns RD, Becker WC, Trafton JA.

Transl Behav Med. 2012 Mar;2(1):57-64. doi: 10.1007/s13142-011-0104-5.

25.

The metabolic syndrome and cognitive performance: the Northern Manhattan Study.

Vieira JR, Elkind MS, Moon YP, Rundek T, Boden-Albala B, Paik MC, Sacco RL, Wright CB.

Neuroepidemiology. 2011;37(3-4):153-9. doi: 10.1159/000332208. Epub 2011 Oct 15.

26.

Reweighting estimators for Cox regression with missing covariate data: analysis of insulin resistance and risk of stroke in the Northern Manhattan Study.

Xu Q, Paik MC, Rundek T, Elkind MS, Sacco RL.

Stat Med. 2011 Dec 10;30(28):3328-40. doi: 10.1002/sim.4380. Epub 2011 Oct 3.

27.

Perception of recurrent stroke risk among black, white and Hispanic ischemic stroke and transient ischemic attack survivors: the SWIFT study.

Boden-Albala B, Carman H, Moran M, Doyle M, Paik MC.

Neuroepidemiology. 2011;37(2):83-7. doi: 10.1159/000329522. Epub 2011 Sep 1.

28.

The inclusion of stroke in risk stratification for primary prevention of vascular events: the Northern Manhattan Study.

Dhamoon MS, Moon YP, Paik MC, Sacco RL, Elkind MS.

Stroke. 2011 Oct;42(10):2878-82. doi: 10.1161/STROKEAHA.111.616912. Epub 2011 Aug 18.

29.

Lower prevalence of silent brain infarcts in the physically active: the Northern Manhattan Study.

Willey JZ, Moon YP, Paik MC, Yoshita M, Decarli C, Sacco RL, Elkind MS, Wright CB.

Neurology. 2011 Jun 14;76(24):2112-8. doi: 10.1212/WNL.0b013e31821f4472. Epub 2011 Jun 8.

30.

Race-ethnic differences in the association between lipid profile components and risk of myocardial infarction: The Northern Manhattan Study.

Willey JZ, Rodriguez CJ, Carlino RF, Moon YP, Paik MC, Boden-Albala B, Sacco RL, DiTullio MR, Homma S, Elkind MS.

Am Heart J. 2011 May;161(5):886-92. doi: 10.1016/j.ahj.2011.01.018.

31.

Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS).

Hudson BI, Moon YP, Kalea AZ, Khatri M, Marquez C, Schmidt AM, Paik MC, Yoshita M, Sacco RL, DeCarli C, Wright CB, Elkind MS.

Atherosclerosis. 2011 May;216(1):192-8. doi: 10.1016/j.atherosclerosis.2011.01.024. Epub 2011 Jan 21.

32.

Social network types and acute stroke preparedness behavior.

Boden-Albala B, Tehranifar P, Stillman J, Paik MC.

Cerebrovasc Dis Extra. 2011 Jan-Dec;1(1):75-83. doi: 10.1159/000328726. Epub 2011 Aug 30.

33.

Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study.

Rundek T, Gardener H, Xu Q, Goldberg RB, Wright CB, Boden-Albala B, Disla N, Paik MC, Elkind MS, Sacco RL.

Arch Neurol. 2010 Oct;67(10):1195-200. doi: 10.1001/archneurol.2010.235.

34.

Early depressed mood after stroke predicts long-term disability: the Northern Manhattan Stroke Study (NOMASS).

Willey JZ, Disla N, Moon YP, Paik MC, Sacco RL, Boden-Albala B, Elkind MS, Wright CB.

Stroke. 2010 Sep;41(9):1896-900. doi: 10.1161/STROKEAHA.110.583997. Epub 2010 Jul 29.

35.

Increased stroke risk and lipoprotein(a) in a multiethnic community: the Northern Manhattan Stroke Study.

Boden-Albala B, Kargman DE, Lin IF, Paik MC, Sacco RL, Berglund L.

Cerebrovasc Dis. 2010 Aug;30(3):237-43. doi: 10.1159/000319065. Epub 2010 Jul 23.

36.

Social determinants of physical inactivity in the Northern Manhattan Study (NOMAS).

Willey JZ, Paik MC, Sacco R, Elkind MS, Boden-Albala B.

J Community Health. 2010 Dec;35(6):602-8. doi: 10.1007/s10900-010-9249-2.

37.

Quality of life declines after first ischemic stroke. The Northern Manhattan Study.

Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, Elkind MS.

Neurology. 2010 Jul 27;75(4):328-34. doi: 10.1212/WNL.0b013e3181ea9f03. Epub 2010 Jun 23.

38.

Metabolic syndrome increases carotid artery stiffness: the Northern Manhattan Study.

Della-Morte D, Gardener H, Denaro F, Boden-Albala B, Elkind MS, Paik MC, Sacco RL, Rundek T.

Int J Stroke. 2010 Jun;5(3):138-44. doi: 10.1111/j.1747-4949.2010.00421.x.

39.

The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke.

Elkind MS, Luna JM, Coffey CS, McClure LA, Liu KM, Spitalnik S, Paik MC, Roldan A, White C, Hart R, Benavente O.

Int J Stroke. 2010 Apr;5(2):117-25. doi: 10.1111/j.1747-4949.2010.00420.x.

40.

A stroke preparedness RCT in a multi-ethnic cohort: design and methods.

Boden-Albala B, Stillman J, Perez T, Evensen L, Moats H, Wright C, Moon-Howard J, Doyle M, Paik MC.

Contemp Clin Trials. 2010 May;31(3):235-41. doi: 10.1016/j.cct.2010.02.003. Epub 2010 Feb 26.

PMID:
20193777
41.

Handling missing responses in generalized linear mixed model without specifying missing mechanism.

Zhang H, Paik MC.

J Biopharm Stat. 2009 Nov;19(6):1001-17. doi: 10.1080/10543400903242761.

PMID:
20183461
42.

HANDLING MISSING DATA BY DELETING COMPLETELY OBSERVED RECORDS.

Paik MC, Wang C.

J Stat Plan Inference. 2009 Jul 1;139(7):2341-2350.

43.

Infectious burden and carotid plaque thickness: the northern Manhattan study.

Elkind MS, Luna JM, Moon YP, Boden-Albala B, Liu KM, Spitalnik S, Rundek T, Sacco RL, Paik MC.

Stroke. 2010 Mar;41(3):e117-22. doi: 10.1161/STROKEAHA.109.571299. Epub 2010 Jan 14.

44.

Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study).

Sacco RL, Khatri M, Rundek T, Xu Q, Gardener H, Boden-Albala B, Di Tullio MR, Homma S, Elkind MS, Paik MC.

J Am Coll Cardiol. 2009 Dec 8;54(24):2303-11. doi: 10.1016/j.jacc.2009.07.047.

45.

Physical activity and risk of ischemic stroke in the Northern Manhattan Study.

Willey JZ, Moon YP, Paik MC, Boden-Albala B, Sacco RL, Elkind MS.

Neurology. 2009 Nov 24;73(21):1774-9. doi: 10.1212/WNL.0b013e3181c34b58.

46.

Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS).

Willey JZ, Xu Q, Boden-Albala B, Paik MC, Moon YP, Sacco RL, Elkind MS.

Arch Neurol. 2009 Nov;66(11):1400-6. doi: 10.1001/archneurol.2009.210.

47.

Infectious burden and risk of stroke: the northern Manhattan study.

Elkind MS, Ramakrishnan P, Moon YP, Boden-Albala B, Liu KM, Spitalnik SL, Rundek T, Sacco RL, Paik MC.

Arch Neurol. 2010 Jan;67(1):33-8. doi: 10.1001/archneurol.2009.271. Epub 2009 Nov 9.

48.

High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study.

Elkind MS, Luna JM, Moon YP, Liu KM, Spitalnik SL, Paik MC, Sacco RL.

Neurology. 2009 Oct 20;73(16):1300-7. doi: 10.1212/WNL.0b013e3181bd10bc.

49.

CKD associates with cognitive decline.

Khatri M, Nickolas T, Moon YP, Paik MC, Rundek T, Elkind MS, Sacco RL, Wright CB.

J Am Soc Nephrol. 2009 Nov;20(11):2427-32. doi: 10.1681/ASN.2008101090. Epub 2009 Sep 3.

50.

Inflammatory biomarkers of vascular risk as correlates of leukoariosis.

Wright CB, Moon Y, Paik MC, Brown TR, Rabbani L, Yoshita M, DeCarli C, Sacco R, Elkind MS.

Stroke. 2009 Nov;40(11):3466-71. doi: 10.1161/STROKEAHA.109.559567. Epub 2009 Aug 20.

Supplemental Content

Support Center